S0859
CAS No. 1019331-10-2
S0859( S0859 | S-0859 | S 0859. )
Catalog No. M10093 CAS No. 1019331-10-2
S0859, an N-cyanosulphonamide compound, reversibly inhibit NBC-mediated pH(i) recovery.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 31 | In Stock |
|
| 5MG | 49 | In Stock |
|
| 10MG | 85 | In Stock |
|
| 25MG | 173 | In Stock |
|
| 50MG | 310 | In Stock |
|
| 100MG | 489 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameS0859
-
NoteResearch use only, not for human use.
-
Brief DescriptionS0859, an N-cyanosulphonamide compound, reversibly inhibit NBC-mediated pH(i) recovery.
-
DescriptionS0859, an N-cyanosulphonamide compound, reversibly inhibit NBC-mediated pH(i) recovery (K (i)=1.7 microM, full inhibition at approximately 30 microM).
-
In VitroTreatment with NBC inhibitor S0859 significantly increased caspase-3 activity and elevated the number of apoptotic EC. S0859 is potentially important for probing the transporter's functional role in heart and other tissues.
-
In Vivo——
-
SynonymsS0859 | S-0859 | S 0859.
-
PathwayOthers
-
TargetOther Targets
-
RecptorNBC
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number1019331-10-2
-
Formula Weight530.04
-
Molecular FormulaC29H24ClN3O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(N(CC1=CC=C(C2=CC=CC=C2S(=O)(NC#N)=O)C=C1)CC3=CC=C(C)C=C3)C4=CC=CC=C4Cl
-
Chemical Name2-chloro-N-((2'-(N-cyanosulfamoyl)-[1,1'-biphenyl]-4-yl)methyl)-N-(4-methylbenzyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Bid BH3 - r8
Bid BH3 - r8
-
Pseudo RACK1
Activator of protein kinase C; attached to cell permeabilization Antennapedia domain vector peptide. Consists of peptide derived from the C2 domain of PKC β linked by a disulfide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the activator peptide. Once inside the cell, the disulfide bonds are subjected to reduction in the cytoplasm leading to release of the activator peptide.
-
E3 Ligase Ligand-Lin...
E3 Ligase Ligand-Linker Conjugates 2 is a synthetic E3 ligase ligand-linker conjugate combining a Pomalidomide-based cereblon ligand and a 4-unit PEG linker.
Cart
sales@molnova.com